Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway
Xingxian Guo, Xiaopeng Li, Peng Zhou, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3419-3419
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy
Sankhadip Bose, Sabyasachi Banerjee, Arijit Mondal, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1451-1451
Open Access | Times Cited: 165
Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma
Caiyan Liu, Shenshen Yang, Kailong Wang, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 120, pp. 109543-109543
Open Access | Times Cited: 144
Evodiamine: A review of its pharmacology, toxicity, pharmacokinetics and preparation researches
Qiang Sun, Long Xie, Jiawen Song, et al.
Journal of Ethnopharmacology (2020) Vol. 262, pp. 113164-113164
Closed Access | Times Cited: 94
Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets
Rui Qin, Feng‐Ming You, Qian Zhao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 67
Comprehensive review of Bcl‐2 family proteins in cancer apoptosis: Therapeutic strategies and promising updates of natural bioactive compounds and small molecules
Iksen Iksen, Wasita Witayateeraporn, Besse Hardianti, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 5, pp. 2249-2275
Closed Access | Times Cited: 13
Repurposing of plant alkaloids for cancer therapy: Pharmacology and toxicology
Thomas Efferth, Franz Oesch
Seminars in Cancer Biology (2019) Vol. 68, pp. 143-163
Closed Access | Times Cited: 72
<p>Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer</p>
Siqi Huang, Zheyu Zhang, Wenqun Li, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 2725-2740
Open Access | Times Cited: 62
Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases
Xiaojiaoyang Li, Junde Ge, Qi Zheng, et al.
Phytomedicine (2020) Vol. 68, pp. 153180-153180
Closed Access | Times Cited: 56
Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers
Munmun Panda, Surya Kant Tripathi, Gökhan Zengin, et al.
Cell Biology and Toxicology (2022) Vol. 39, Iss. 1, pp. 1-31
Closed Access | Times Cited: 34
Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway
Shuang Zhao, Ke Xu, Rong Jiang, et al.
Life Sciences (2020) Vol. 251, pp. 117424-117424
Closed Access | Times Cited: 43
Research progress on evodiamine, a bioactive alkaloid of Evodiae fructus: Focus on its anti‑cancer activity and bioavailability (Review)
Chaodan Luo, Jingwen Ai, Erfang Ren, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 33
Traditional Chinese medicine Euodiae Fructus: botany, traditional use, phytochemistry, pharmacology, toxicity and quality control
Si-Jia Xiao, Xi‐Ke Xu, Wei Chen, et al.
Natural Products and Bioprospecting (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells
Zhong Hong, Zhaohong Wang, Bin Zhou, et al.
International Journal of Oncology (2020)
Open Access | Times Cited: 39
Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights
S. M. E. HASSAN, Alyaa Farid, Siva S. Panda, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 922-922
Open Access | Times Cited: 4
Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment
Yanming Luo, Shuangshuang Yin, Jia Lu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Mechanism of evodiamine blocking Nrf2/MAPK pathway to inhibit apoptosis of grass carp hepatocytes induced by DEHP
Yutian Lei, Wenyue Zhang, Meichen Gao, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2022) Vol. 263, pp. 109506-109506
Closed Access | Times Cited: 19
High expression of nucleotide-binding oligomerization domain protein 1 correlates with poor prognosis and immune cell infiltration in Glioblastoma Multiforme patients
Hongyang Zhao, Beiwu Lan, Zenghui Zhao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Metformin Inhibits the Urea Cycle and Reduces Putrescine Generation in Colorectal Cancer Cell Lines
Tao Zhang, Ling Hu, Jia-Feng Tang, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 1990-1990
Open Access | Times Cited: 21
Design, synthesis and bioactivity evaluation of favorable evodiamine derivative scaffold for developing cancer therapy
Ziyi Liang, Yuqing Wang, Honghua Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 239, pp. 114530-114530
Closed Access | Times Cited: 16
miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3
Meng Wang, Guoyue Lv, Chao Jiang, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 25
NOD-like receptors in the pathogenesis of metabolic (dysfunction)-associated fatty liver disease: Therapeutic agents targeting NOD-like receptors
Shaghayegh Khanmohammadi, Bruno Ramos‐Molina, Mohammad Shafi Kuchay
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 7, pp. 102788-102788
Closed Access | Times Cited: 8
MiR-372-3p Functions as a Tumor Suppressor in Colon Cancer by Targeting MAP3K2
Yana Li, Fuqiang Li, Chang Feng, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 12
Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-κB Signaling Pathway
Yuhe Lei, Mei-Ching Chan, Haiyan Liu, et al.
Disease Markers (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 12
Progress on the effects and underlying mechanisms of evodiamine in digestive system diseases, and its toxicity: A systematic review and meta-analysis
Zubing Zhou, Zhou Yan, Zhongyi Zhang, et al.
Phytomedicine (2024) Vol. 132, pp. 155851-155851
Open Access | Times Cited: 2
Fermented sea buckthorn compound juice inhibits colorectal cancer growth by regulating immunity and the gut microbiome
Yu Fu, Ziqing Liu, Kaihua Wang, et al.
Journal of Functional Foods (2024) Vol. 121, pp. 106408-106408
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top